Concepedia

An Open-Label Study of Aripiprazole: Pharmacokinetics, Tolerability, and Effectiveness in Children and Adolescents with Conduct Disorder

Robert L. Findling, Ralph E. Kauffman, Floyd R. Sallee, Daniel E. Salazar, Vaishali Sahasrabudhe, Georgia Kollia, David M. Kornhauser, Nimish N. Vachharajani, Sheila Assunção-Talbott, Suresh Mallikaarjun,

Journal of Child and Adolescent Psychopharmacology · 2009 · 53 citations · 25 references

DOI

Abstract

The pharmacokinetics of aripiprazole in children and adolescents are linear and comparable with those in adults. Aripiprazole was generally well-tolerated in patients with CD, particularly after protocol adjustments, with improvements in aggressive behavior.

References

25

Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): Initial Reliability and Validity Data

Joan Kaufman, Boris Birmaher, David A. Brent et al. · Journal of the American Academy of Child & Adolescent Psychiatry · 1997 · 10.1K citations · Full text

ECDEU Assessment Manual for Psychopharmacology

William Guy · Bulletin of Miscellaneous Information (Royal Gardens Kew) · 1976 · 8.8K citations

, , +6

A Simple Objective Technique for Measuring Flexibility in Thinking

Esta A. Berg · The Journal of General Psychology · 1948 · 2.2K citations

, , +14

Aripiprazole, A Novel Atypical Antipsychotic Drug with a Unique and Robust Pharmacology

Sean M Renock, Elaine G. Arrington, Louis A. Chiodo et al. · Neuropsychopharmacology · 2003 · 962 citations · Full text

, , +9

Aripiprazole, a Novel Antipsychotic, Is a High-Affinity Partial Agonist at Human Dopamine D2 Receptors

Kevin D. Burris, Thaddeus F. Molski, Cen Xu et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 914 citations